Health Funding Solution: Steps by National Treasury
Explore the health funding solution proposed by the National Treasury to address critical shortfalls in South Africa's healthcare system.
Global Fund Replenishment: Addressing Critical Needs
Learn why Global Fund replenishment is critical to combat AIDS, TB, and malaria amid severe health financing cuts.
Gilead’s Lenacapavir to Reach High-Burden Nations ‘At Cost’
Gilead’s Lenacapavir is set to revolutionise HIV prevention efforts, aiming to protect two million people across affected nations.
Pharma Giants Sidelined in R15.5bn HIV Drug Tender
The recent R15.5 billion ARV tender sidelines Pharma Giants in South Africa, raising questions about local production support.
TAC Seeks to Join Legal Fray Over NHI Act
The Treatment Action Campaign seeks to join the court challenge against the NHI Act, voicing concerns for public health users.
SA Life Expectancy Gains and Public Health Advances
StatsSA reports a remarkable 12-year increase in SA life expectancy at birth. Discover the implications for public health.
PEPFAR Funding Secure for Vital HIV Programmes
The United States Congress has spared the President’s Emergency Plan for AIDS Relief (PEPFAR), a cornerstone of global HIV/AIDS prevention for nearly two decades, from a potential $400 million budget cut.. The proposed reduction was part of the Trump administration’s wider “rescissions package.” This package aimed at clawing back $9.4 billion in previously approved federal…...
Motsoaledi’s Budget Aims to Strengthen Health System
Explore Motsoaledi's budget of R64.8 billion aimed at enhancing South Africa's healthcare infrastructure and reversing austerity measures.
HIV Prevention Strategies with Lenacapavir Injection
In a decision that could fundamentally reshape the fight against HIV, the US Food and Drug Administration (FDA) has given its approval to Gilead Sciences’ lenacapavir, a groundbreaking twice-yearly injection for preventing HIV infection in adults and adolescents. Marketed under the brand name Yeztugo in the US, this innovative drug has been eagerly anticipated by…...
Global Health Giants Consider Merger Amidst Funding Crunch
Examine the significance of collaboration between the Global Fund and Gavi in responding to the global health financing crisis.